News & Updates

Show Multimedia Only

Which medications actually work for chronic migraine?

22 May 2026

Several calcitonin gene-related peptide-targeted therapies show potential efficacy for the treatment of chronic migraine, suggest the results of a systematic review.

Which medications actually work for chronic migraine?

22 May 2026

Hypercholesterolemia does not worsen cognitive decline in arterial hypertension

21 May 2026

The presence of hypercholesterolemia shows no negative impact on cognitive function among individuals with hypertension, reports a study.

Hypercholesterolemia does not worsen cognitive decline in arterial hypertension

21 May 2026

Lecanemab continues to delay progression in AD at 4 years

20 May 2026 by

The 48-month analysis of the global phase III Clarity AD study shows that lecanemab continues to deliver benefit and delay progression in early Alzheimer's disease (AD).

Lecanemab continues to delay progression in AD at 4 years

20 May 2026

Housing type, sedentary behaviour influence risk of diabetic peripheral neuropathy

19 May 2026 by

In a recent study from Singapore, housing type and sedentary behaviour have emerged as novel risk factors for diabetic peripheral neuropathy.

Housing type, sedentary behaviour influence risk of diabetic peripheral neuropathy

19 May 2026

Non-use of intracranial pressure monitoring does not elevate ICH risk in ALF patients

19 May 2026

The use of invasive intracranial pressure monitoring (IICPM) in three high-volume liver transplant centres has declined over 10 years with no associated worsening of outcomes among patients with acute liver failure (ALF), according to a study.

Non-use of intracranial pressure monitoring does not elevate ICH risk in ALF patients

19 May 2026

Nipocalimab + SoC sustains disease control in patients with myasthenia gravis

19 May 2026 by

Adding nipocalimab to standard-of-care (SoC) demonstrates sustained disease control through week 120 in adult patients with antibody-positive generalized myasthenia gravis (gMG), including anti-AChR* or anti-MuSK**, according to the Vivacity-MG3 open-label extension (OLE) study presented at AAN 2026.

Nipocalimab + SoC sustains disease control in patients with myasthenia gravis

19 May 2026

Supervised home-based cardiorespiratory interval training reduces post-stroke fatigue

17 May 2026

A home-based, supervised cardiorespiratory interval training program (HS-CITP) helps lessen fatigue among stroke survivors, as shown in a study.

Supervised home-based cardiorespiratory interval training reduces post-stroke fatigue

17 May 2026

Folic acid supplementation may prevent adverse offspring outcomes in ASM-exposed pregnancies

16 May 2026

In pregnant women exposed to antiseizure medications (ASMs), supplementation with folic acid helps lower the risk of adverse offspring outcomes, according to a study.

Folic acid supplementation may prevent adverse offspring outcomes in ASM-exposed pregnancies

16 May 2026

Anaemia linked to increased dementia risk

14 May 2026 by

Individuals with low haemoglobin levels, especially those with elevated concentrations of Alzheimer’s disease (AD) biomarkers, are at greater risk of developing dementia, as suggested in new research.

Anaemia linked to increased dementia risk

14 May 2026

Investigational calcium channel modulator alleviates central neuropathic pain

13 May 2026 by

The novel third-generation calcium channel modulator crisugabalin appears to be safe and efficacious in the treatment of central neuropathic pain, as shown in a phase 3 trial.

Investigational calcium channel modulator alleviates central neuropathic pain

13 May 2026

News & Updates

Showing Neurology articles

Showing

Specialty:

Which medications actually work for chronic migraine?

Which medications actually work for chronic migraine?

Hypercholesterolemia does not worsen cognitive decline in arterial hypertension

Hypercholesterolemia does not worsen cognitive decline in arterial hypertension

Lecanemab continues to delay progression in AD at 4 years

Lecanemab continues to delay progression in AD at 4 years

Housing type, sedentary behaviour influence risk of diabetic peripheral neuropathy

Housing type, sedentary behaviour influence risk of diabetic peripheral neuropathy

Non-use of intracranial pressure monitoring does not elevate ICH risk in ALF patients

Non-use of intracranial pressure monitoring does not elevate ICH risk in ALF patients

Nipocalimab + SoC sustains disease control in patients with myasthenia gravis

Nipocalimab + SoC sustains disease control in patients with myasthenia gravis

Supervised home-based cardiorespiratory interval training reduces post-stroke fatigue

Supervised home-based cardiorespiratory interval training reduces post-stroke fatigue

Folic acid supplementation may prevent adverse offspring outcomes in ASM-exposed pregnancies

Folic acid supplementation may prevent adverse offspring outcomes in ASM-exposed pregnancies

Anaemia linked to increased dementia risk

Anaemia linked to increased dementia risk

Investigational calcium channel modulator alleviates central neuropathic pain

Investigational calcium channel modulator alleviates central neuropathic pain